Using colony formation assays on three CRC cell lines, we observed that each inhibitor, corresponding to EGFR, HGFR, or ALK, enhanced the inhibitory effect of low-dose celastrol (Figure 2C), indicating that combination treatment is more effective for long-term inhibition of cell proliferation. Here, MET is linked to colorectal carcinoma.